3rd Protein-Protein Interaction
October 22 - 23, 2015 - Boston CA USGlobal Technology Community
infogtcbio@gtcbio.com
Phone:626-256-6405
Fax:626-466-4433
The relatively new field of protein-protein interaction (PPI) is experiencing fantastic growth in the field of drug discovery. The key concepts of PPI are to understand how proteins interact, to understand why inhibiting them is beneficial, and how to identify molecules that block the interactions as treatment strategies. GTCbio's upcoming 3rd Protein-Protein Interaction Conference to be held on October 22-23, 2015 in Boston, MA will have sessions that cover novel techniques, new algorithms and databases for PPIs, and potential druggable sites for disrupting protein-protein interactions. Attendees will gain an enhanced understanding of the molecular basis of peptide and protein aggregation and insights into the design of inhibitors of peptide and protein aggregation. Some focused topics we will discuss is how inhibiting PPIs can be a promising therapeutic target, PPI interactions within the TNF family, the first small-molecule inhibitors for the CD40–CD40L, and much more including the fundamental aspects of protein-protein interactions.